Caredx Inc (NASDAQ:CDNA) price on Friday, March 21, rose 2.22% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $19.32.
A look at the stock’s price movement, the close in the last trading session was $18.90, moving within a range at $18.24 and $19.36. The beta value (5-Year monthly) was 1.952 while the PE ratio in trailing twelve months stood at 18.99. Turning to its 52-week performance, $34.84 and $7.42 were the 52-week high and 52-week low respectively. Overall, CDNA moved -17.37% over the past month.
Caredx Inc’s market cap currently stands at around $1.07 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-25.
Analysts have a consensus estimate of 84.56M for the company’s revenue for the quarter, with a low and high estimate of 83.18M and 86.4M respectively. The average forecast suggests up to a 17.36% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 370.85M, representing a 11.10% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CDNA is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend CDNA as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CDNA’s current price about -1.82% and -11.49% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 44.43, while 7-day volatility ratio is 4.27% and 6.05% in the 30-day chart. Further, Caredx Inc (CDNA) has a beta value of 2.16, and an average true range (ATR) of 1.20. Analysts have given the company’s stock an average 52-week price target of $30, forecast between a low of $25 and high of $35. Looking at the price targets, the low is -29.4% off current price level while to achieve the yearly target high, price needs to move -81.16%. Nonetheless, investors will most likely welcome a -55.28% jump to $30 which is the analysts’ median price.
If we refocus on Caredx Inc (NASDAQ:CDNA), historical trading data shows that trading volumes averaged 0.7 over the past 10 days and 845.35K over the past 3 months. The company’s latest data on shares outstanding shows there are 54.77 million shares.
The 6.29% of Caredx Inc’s shares are in the hands of company insiders while institutional holders own 100.45% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 5.18 million on 2025-02-28, giving us a short ratio of 5.5. The data shows that as of 2025-02-28 short interest in Caredx Inc (CDNA) stood at 1218.9999 of shares outstanding, with shares short rising to 4.46 million registered in 2025-01-31. Current price change has pushed the stock -9.76% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CDNA stock continues to rise going into the next quarter.
